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Epidermal integrity is a complex process established
during embryogenesis and maintained throughout
the organism lifespan by epithelial stem cells.
Although Wnt regulates normal epithelial stem cell
renewal, aberrant Wnt signaling can contribute to
cancerous growth. Here, we explored the conse-
quences of persistent expressing Wnt1 in an
epidermal compartment that includes the epithelial
stem cells. Surprisingly, Wnt caused the rapid
growth of the hair follicles, but this was followed by
epithelial cell senescence, disappearance of the
epidermal stem cell compartment, and progressive
hair loss. Although Wnt1 induced the activation of
b-catenin and the mTOR pathway, both hair follicle
hyperproliferation and stem cell exhaustion were
strictly dependent on mTOR function. These findings
suggest that whereas activation of b-catenin contrib-
utes to tumor growth, epithelial stem cellsmay be en-
dowed with a protective mechanism that results in
cell senescence upon the persistent stimulation of
proliferative pathways that activatemTOR, ultimately
suppressing tumor formation.
INTRODUCTION
The Wnt family consists of 19 secreted cysteine-rich glycopro-
teins that initiate signaling by interacting with the N-terminal
extracellular cysteine-rich region of the Frizzled family of
seven-span transmembrane receptors and with either LRP5 or
LRP6, two members of the low-density-lipoprotein receptor-
related (LDL-R) protein family (Moon et al., 2004; Nusse, 2008).
Wnt can stimulate several major signaling cascades including
the canonical Wnt/b-catenin pathway, wherein b-catenin is
stabilized and translocates to the nucleus, and the noncanonical
Wnt pathways, which include the PCP (planar cell polarity), c-Jun
amino-terminal kinase (JNK), Rho, and calcium signaling path-
ways (reviewed in Moon et al., 2004; Reya and Clevers, 2005).
Inappropriate activation of the Wnt/b-catenin pathway has
been implicated in a large number of highly prevalent tumors,
supporting an important role of this pathway in promoting cellCegrowth (Brennan and Brown, 2004; Klaus and Birchmeier,
2008). In addition, a large body of data shows that Wnt function
is required for embryonic development and tissue maintenance
and regeneration in adults (Liu et al., 2008). Specifically, Wnt
controls a variety of processes ranging from gastrulation to
organogenesis, including the heart, mammary gland branching,
and the development of blood vessels, kidneys, and lung, and
thus often contributes to developmental events that involve
epithelial-mesenchymal interactions (Klaus and Birchmeier,
2008; Moon et al., 2004; Nusse, 2008; Reya and Clevers, 2005).
In the epidermis, hair follicle (HF) development is initiated
when mesenchymal cells populate the skin. During this process,
signals emanating from the dermis induce epithelium thickening,
elongation of the epithelial cells, and the formation of placodes
containing Wnt-responsive cells (Andl et al., 2002) (reviewed in
Alonso and Fuchs, 2003; Blanpain and Fuchs, 2009; Maretto
et al., 2003). In response, placodes signal dermal cells to
condense, thereby forming the dermal papilla component of
the HF, which is also responsive to Wnt signaling (Maretto
et al., 2003). The fully formed HF then retains detectable levels
of b-catenin in the precortex, dermal papilla, and matrix cells
(Maretto et al., 2003; Reddy et al., 2001), in which it contributes
to the maintenance of HF structures.
The ability to self-renew and generate differentiated progeny is
what defines a stem cell. Embryonic stem cells are pluripotent
and thus capable of generating any tissues of the body; however,
the maintenance of most adult tissues is dependent on the pres-
ence of tissue-specific self-renewing somatic stem cells, which
have a more restricted differentiation potential and can regen-
erate only some of the cell types of the tissues from which they
are derived (reviewed in Blau et al., 2001). Among a limited
number of signaling networks controlling stem cell function,
the canonical Wnt/b-catenin pathway has emerged as a key
regulator of stem cell self-renewal (Alonso and Fuchs, 2003;
Nusse, 2008). For example, activation of b-catenin by Wnt
contributes to the inhibition of keratinocytes differentiation (Zhu
and Watt, 1999), induction of hair follicle formation (Gat et al.,
1998), and maintenance of proliferation of neuronal progenitors
(Zechner et al., 2003). Wnt3A and 5A are also able to modulate
the self-renewal of hematopoietic stem cells and increase the
number of their progenitors (Nusse, 2008). However, expression
of dominant active form of b-catenin may exert a negative effect
on hematopoietic stem cells, leading to multilineage differentia-
tion impairment and the consequent loss of stem cell activityll Stem Cell 5, 279–289, September 4, 2009 ª2009 Elsevier Inc. 279
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(A) The hair follicles grow in a cyclic fashion, involving a growth phase or anagen, an involution phase (catagen), and a resting phase (telogen).
(B) H&E sections of the first synchronous hair cycle from K5rtTA control animals showing the histological characteristic of each phase at the indicated days of age
(upper panel). Typical examples of K5rtTA/tet-Wnt1mice treated with doxycycline showing early entry into a growth phase followed by failure to undergo catagen
and telogen (lower panel) are shown.(Kirstetter et al., 2006; Scheller et al., 2006). Wnt may also play a
role in activating cell senescence programs, as we have recently
shown in the klotho animal model of aging (Liu et al., 2007).
Here, we investigate the long-term consequences of ectopic
Wnt1-induced signaling in the epithelial compartment of the
skin. Surprisingly, we found that Wnt causes the rapid growth
of the HF, but this was followed by the disappearance of the
epidermal stem cell compartment and progressive, premature
hair loss. Although Wnt1 expression induced the activation of
both b-catenin and mTOR in the epithelial compartment of the
skin, both HF growth and stem cell exhaustion were uniquely
associated with mTOR activation. These findings suggest that
epidermal stem cells may be endowed with a protective mecha-
nism resulting in cell senescence upon the persistent stimulation
of growth promoting pathways that activate mTOR, thereby
helping to maintain the genetic integrity of the stem cell popula-
tion, which may ultimately contribute to suppress tumor forma-
tion.
RESULTS
Wnt1 Induces the Persistent Maintenance
of Growth Phase, Anagen-like HF Structures
To evaluate the effects ofWnt1 in the epidermis, we conditionally
expressed theWnt1 gene by crossing mice carrying the cytoker-
atin 5 promoter (K5) expressing the reverse tetracycline transac-
tivator (rtTA) (Vitale-Cross et al., 2004) with FVB/Nmice express-
ing the murine Wnt1 gene containing an IRES-firefly luciferase
under the control of seven tet-responsive elements (tet-Wnt1)
(Gunther et al., 2003). The offspring from this cross followed a
normal Mendelian distribution, and no lethality was observed
upon tet-on system activation during development by the admin-
istration of doxycycline to pregnant mice, although the double-280 Cell Stem Cell 5, 279–289, September 4, 2009 ª2009 Elsevier Intransgenic mice were slightly smaller than their controls (not
shown). Thus, we focused our attention on the effects of Wnt1
during the postnatal HF morphogenesis. The development of
HF can be divided into eight distinct stages that are initiated
during embryogenesis and culminate soon after animal birth
(Paus et al., 1999). The last stage of HF morphogenesis (stage 8)
involves a growth phase often referred to as anagen (Greco et al.,
2009; Paus et al., 1999), which is followed by the nearly synchro-
nous entrance into the catagen and telogen phases, after a well-
defined pattern during this first hair cycle (Figure 1A). During the
growth phase (anagen), the lower cycling part of the HF is
shaped by the differentiation of the keratinocytes into the outer
root sheet (ORS) and the inner root sheet (IRS). The IRS is
composed of the outer Henley’s layer, followed by the Huxley’s
layer and the cuticle that separates the IRS from the hair shaft
(Ito, 1986). During catagen, the HF undergoes an involution
process mainly driven by apoptosis of the lower half of the HF.
Telogen is the last stage of the hair cycle in which quiescent
epithelial cells from the upper half of the HF remain quiescent
until receiving new stimulation for growth (Morris et al., 2004).
In order to analyze the consequences ofWnt1 expression during
this first hair cycle, we selected four time points, 7, 14, 17, and 21
days of age (Figure 1B). We observed that upon doxycycline
treatment, all K5rtTA/tet-Wnt1 transgenic mice entered prema-
turely into a rapid growth phase when compared to control litter-
mates. This induction resulted in accelerated, yet controlled, HF
growth with formation of all HF sheaths (ORS and IRS). However,
unlike control littermates, HF from mutant mice failed to enter
catagen and telogen. Consistent with this, K5rtTA/tet-Wnt1
mice maintained the skin thickness found during anagen,
preserving the lower half of the HF in the subcutis at day 17
and 21, which was quite distinct from control littermates that
were in catagen and telogen, respectively (Figure 1B). Similarc.
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available online), suggesting thatWnt1 promotes the persistence
of HF in a growth phase, instead of undergoing consecutive
cycles of growth and involution.
Figure 2. Alterations in HF Structures in K5rtTA/tet-Wnt1 Mice
(A) As shown in the upper panel, frozen sections from skin of 21-day-old (P21)
K5rtTA control mice show typical localization of the terminal differentiation
marker fillagrin in the uppermost layers of epidermis. The normal localization
of cytokeratin 1 (K1) and 10 (K10) in the spinous layer of the interfollicular
compartment and the normal expression of cytokeratin 6 (K6) in the HF are
shown. Expression of a6 integrin (a6) delimitates the epidermal from the
dermal compartment. DAPI was used for nuclear DNA staining (blue). As
shown in the lower panel, K5rtTA/tet-Wnt1 mice fed with doxycycline show
normal localization of fillagrin, cytokeratin 1, cytokeratin 10, and absence of
cytokeratin 6 in the interfollicular epidermis (IF). HFs of mutant mice do not
express fillagrin and cytokeratin 1; however, an abnormal expression of cyto-
keratin 10 is present in the IRS compartment, colocalized with normal expres-
sion of cytokeratin 6.
(B) During late-stagemorphogenesis (P14), K5rtTA controlmice express Type I
hair keratins AE13 and the IRS-specific marker (mIRSa). Expression of these
markers cease during telogen (P21). K5rtTA/tet-Wnt1 mice fed with doxycy-
cline instead maintain the expression of both markers through P21, consistent
with the failure to enter in a resting state. Cytokeratin 5 (K5) staining reveals the
basal epithelial layer. High magnification (633) shows details of AE13 and
mIRSa expressing structures in K5rtTA/tet-Wnt1 mice.CeTo further characterize the HF structure from mutant mice, we
used specific differentiation markers for the spinous (cytokeratin
1 and 10) and cornified (fillagrin) layers (Fuchs, 1995). We also
assessed HF markers such as the type II keratin 6, which is
present in the innermost cell layer of the ORS (Fuchs, 1995);
the AE13 Type I hair keratin that is present in the hair cortex
(Lynch et al., 1986); and mIRSa, which is a marker for the IRS
(Porter et al., 2004) (Figures 2A and 2B). There were no evident
alterations in the differentiation pattern of the interfollicular
epidermis of K5rtTA/tet-Wnt1 mice (Figure 2A). However, when
examining the structure of the hair follicles by day 21, we found
aberrant expression of cytokeratin 10 in the ORS layer of the hair
follicle, and such an expression was not present in the control
littermates that were in telogen (Figure 2A). The 21-day-old
mutant mice maintained the expression of HF markers, such
as AE13 and mIRSa, which were present in control littermates
during late-stage morphogenesis/anagen (P14) but not during
telogen (P21) (Figure 2B). Thus, the expression of Wnt1 causes
mice to persistently retain fully developed HF rather than
entering in catagen and telogen.
Wnt1 Activates the b-Catenin Pathway in HF:
Prolonged Exposure to Wnt1 Leads to Hair Loss
We next explored the expression and activity of the Wnt1 down-
stream molecule b-catenin. Both mutant and control mice ex-
hibited widespread expression of b-catenin in the interfollicular
region of the skin as well as in the follicular compartment,
including the bulge and bulb anatomical areas (Figure 3A).
Although membrane and cytoplasmatic localization of b-catenin
was readily detectable, no nuclear b-catenin staining could be
observed, possibly because of the strong signal frommembrane
staining or the limited presence of nuclear b-catenin. However,
K5-promoter-driven expression of Wnt1 induced proliferation
primarily of the cells within the basal K5-expressing layer of the
HF, as assessed by BrDU incorporation and cyclin D1 expres-
sion (Figure 3B and Figure S2).
To ensure the specificity of our K5-driven tet-Wnt1-IRES-
firefly luciferase mice, we analyzed the expression of luciferase
by immunohistochemistry, which showed a strong reactivity in
the K5-expressing layers comprising the ORS of mutant mice
(Figure 3C). Next, we performed a detailed analysis of the b-cat-
enin activation status. Using a specific antibody that recognizes
the dephosphorylated form of b-catenin on Ser37 or Thr41, the
active form of b-catenin (van Noort et al., 2002), we found cyto-
plasmatic localization of active b-catenin confined to the IRS,
adjacent to the compartment expressing luciferase in the K5
layer (Figure 3C). Thus, Wnt1 expression may cause the para-
crine activation of b-catenin in the adjacent HF epithelial layers.
Whether this involves the contribution of particular Wnt1 recep-
tors that are in the HF matrix and that might be absent in the
ORS, as recently reported (Reddy et al., 2004), warrants further
investigation. To further examine this paracrine effect, we made
use of the b-catenin reporter mouse line BAT-Gal, which ex-
presses the lacZ gene under the control of b-catenin/T cell-
factor-responsive elements (Maretto et al., 2003), and crossed
these mice with the K5rtTA/tet-Wnt1 mouse line. Indeed, LacZ
detection of b-Gal activity was detected during the growth phase
of the first hair cycle in control littermates (P14) and in 21-day-old
mutant mice, at a time in which no b-Gal activity could bell Stem Cell 5, 279–289, September 4, 2009 ª2009 Elsevier Inc. 281
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Targets in the Epidermis and HF of Doxycy-
cline-Treated K5rtTA/tet-Wnt1 Mice
(A) Presence of total b-catenin in control and
mutant mice. Representative immunofluores-
cence analysis for total b-catenin (green), cytoker-
atin 14 (K14) (red), and DAPI (blue) in skins from
control and K5rtTA/tet-Wnt1 fed with doxycycline
are shown. High magnifications show membrane
and cytoplasmatic localization of b-catenin.
(B) Hyperproliferation of epithelial HF cells in
K5rtTA/tet-Wnt1 mice. The bar graphs represent
the number of BrDU-positive cells as the average ±
SEM of ten fields at 203 magnification in repre-
sentative animals of the indicated genotype fed
with doxycycline (***p < 0.001).
(C) IHC for luciferase (Luc) shows negative staining
in control littermates on P14 and P21 and positive
staining in the ORS of K5rtTA/tet-Wnt1 mice
aligned with the expression of the transgenic
construct. Accumulation of the unphosphorylated,
active form of b-catenin (Act b-Cat) in the HF IRS of
mutant mice was noticeable. However, the active
form of b-catenin was not detected by IHC in
P14 and P21 control littermates. Using a reporter
mouse line for b-catenin (BAT-Gal mouse) bred
into our mouse lines, we were able to detect b-cat-
enin activity at P14 (growth phase) but not at P21
(telogen) in control mice. K5rtTA/tet-Wnt1 mice
crossed with BAT-Gal mice, however, showed
a strong activation of the b-catenin pathway visu-
alized by the expression of b-Gal staining in the
IRS. IHC reaction for WISP-1 (Wnt1-induced
secreted protein 1) was observed in the IRS of
the HF of K5rtTA/tet-Wnt1 mice but not in the
K5rtTA control mice. Accumulation of high levels
of the phosphorylated form of S6 (p-S6) was
readily detectable in the IRS compartment of the
HF upon Wnt-1 expression, and during late-stage
morphogenesis in control littermates (P14), but
absent during telogen (P21).observed in control mice that were already in telogen (P21)
(Figure 3C). Furthermore, we also examined the expression of
endogenous Wnt-regulated molecules in this HF compartment.
For example, by IHC analysis, wewere able to detect the expres-
sion of WISP-1 (Wnt1-induced secreted protein 1), a b-catenin-
regulated molecule (Xu et al., 2000), in the IRS compartment of
hair follicles in mutant mice (P21) (Figure 3C), consistent with
the analysis of b-catenin-activated gene expression by the
b-Gal reporter system. On the basis of recent studies supporting
the finding that the unconventional protein kinase mTOR repre-
sents a direct target of the Wnt pathway (Inoki et al., 2006), we
also characterized the levels of the phosphorylated form of the
mTOR downstream molecule, S6 (Wendel et al., 2004). Trans-
genic Wnt1 expression provoked a very strong accumulation
of pS6 at the IRS when compared with control littermates
(Figure 3C), with a pattern similar to that of WISP-1 staining,
active b-catenin accumulation, and b-Gal reporter activity. Over-
all, these observations suggest that Wnt1-secreting cells local-282 Cell Stem Cell 5, 279–289, September 4, 2009 ª2009 Elsevier Iized at the ORS induce paracrine activation of Wnt-downstream
targets in the IRS compartment of HF.
We analyzed the prolonged effects of Wnt1 by following a
cohort of mutant and wild- type littermates (n = 25) for >1 year.
Although transgenic expression of active b-catenin from the
K14 promoter leads to the tumoral growth of HF (pilomatrico-
mas) (Gat et al., 1998), prolonged exposure to Wnt1 caused a
quite distinct biological outcome. The persistent proliferative an-
agen-like phenotype observed in K5rtTA/tet-Wnt1 mice evolved
into a progressive hair loss (Figure 4A) reflected microscopically
by the expansion of all sheaths, which was quite evident during
the second hair cycle (Figure S1) when compared to control
mice. Doxycycline-induced Wnt1 expression caused the
terminal differentiation of HF after 90 days (Figure 4B). Subse-
quently, the ORS, bulge, and sebaceous glands differentiate
into cyst-like structures after prolonged Wnt1 expression (Fig-
ure 4B and Figure S3A). Secondary periappendageal dermal
inflammation with multinuclear giant cells was also observednc.
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a progressive decrease on HF density (Figures 4B and 4C; Fig-
ure S3B). However, no major alterations other than a moderate
acanthosis (thickening of the epithelial compartment) was
observed in the IF epidermis (Figure S3C).
Wnt1 Induces Senescence and Impairs
the Regenerative Capacity of HF
by Causing Stem Cell Ablation
The progressive changes in the HF structures and subsequent
hair loss led us to explore whether prolonged exposure to
Wnt1 induces cell apoptosis or senescence. While we could
not detect the accumulation of apoptotic cells in response to
Wnt1 expression (not shown), we observed that Wnt1 can
promote cell senescence as judged by the detection of DNA
double-strand breaks revealed by the presence of g-H2AX foci
in cell nuclei (Motoyama and Naka, 2004) and the expression
of endogenous b-Gal activity at pH 6, a known characteristic of
senescent cells (SAb-Gal) (Dimri et al., 1995) (Figures 5A
and 5B). Surprisingly, this correlated with the complete absence
of CD34+ HF stem cells when compared to littermates (Fig-
Figure 4. Progressive Premature Hair Loss in K5rtTA/tet-Wnt1 Mice
(A) K5rtTA/tet-Wnt1 transgenic mice fed with doxycycline show complete loss
of their fur by 1 year of age when compared with K5rtTA control littermates.
(B) H&E histological sections of K5rtTA and K5rtTA/tet-Wnt1 by 21, 90, and
360 days of age showing progressive HF degeneration when compared to
normal K5rtTA control mice. K5rtTA/tet-Wnt1 mice present a growth phase,
anagen-like phenotype by 21 days of age, which evolves into altered HF
structures and subsequent HF loss.
(C) Quantification of hair follicles was performed with histological sections cut
in parallel to the surface of the epidermis. The bar graphs represent the number
of hair follicles at the indicated age as the average ± SEM of ten fields at
103 magnification from representative animals of the indicated genotype
(***p < 0.001; **p < 0.01; ns, p > 0.05).Ceure 5C). To confirm these results, we analyzed the impact of
Wnt1 expression on CD34+ cells expressing high levels of a6 in-
tegrin and on those expressing low levels of a6 integrin, each of
which represent a distinct subpopulation of hair follicle stemcells
Figure 5. Induction of Senescence and Loss of CD34+ Epithelial
Stem Cells in K5rtTA/tet-Wnt1 Mice
(A) Frozen skin sections of K5rtTA and K5rtTA/tet-Wnt1 mice fed with doxycy-
cline (Doxy) showing SA b-Gal reactivity as amarker of senescence.Mutant HF
are positive for this senescence marker, whereas the control sample present
no staining for SAb-Gal. Foci of IF staining for the double-strand DNA-damage
marker g-H2AX was observed in the nuclei of HF from K5rtTA/tet-Wnt1 mice
(g-H2AX-red and nuclear staining with DAPI). Higher magnifications are shown
below.
(B) Quantification of g-H2AX foci in HF from mutant and K5rtTA control mice.
Bar graphs represent the quantitative analysis of positive HF, as the average ±
SEM of the number of HF presenting g-H2AX-positive cells in ten fields at 203
magnification from representative animals of the indicated genotype and
treatment (**p < 0.01; *p < 0.05).
(C) Frozen skin samples were sectioned and stained for keratin 5 (K5) (red) and
CD34 (green) markers. K5rtTAmice display strong andwell-demarked staining
for CD34 at the bulge compartment of the HF, whereas no CD34+ cells were
observed in the HF of K5rtTA/tet-Wnt1 mice fed with doxycyline. Higher
magnifications (lower left) show the presence of CD34+ cells (indicated by
an arrow) in K5rtTA control mice but absence of CD34+ cells in the K5rtTA/
tet-Wnt1 mice (indicated by an arrow).
(D) A cohort of six mice per group was shaved simultaneously with the admin-
istration of doxycycline diet. By day 28, K5rtTA mice have completely recov-
ered dorsal fur, whereas K5rtTA/tet-Wnt1 doxycycline treated mice failed to
recover the shaved area. Representative mice are shown.ll Stem Cell 5, 279–289, September 4, 2009 ª2009 Elsevier Inc. 283
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analysis of 7-week-old K5rtTA/tet-Wnt1 and control littermate
double labeled for CD34 and a6 integrin (CD49f) showed
a dramatic reduction in the number of both populations of stem
cells (CD34hi a6hi and CD34hi a6low) in the K5rtTA/tet-Wnt1
mice (Figures S4A and S4B), supporting the emerging notion
that Wnt1 promotes the ablation of the hair follicle stem cell
compartment.Wenext ran a functional assay to assess the ability
of the stem cell population of our K5rtTA/tet-Wnt1 mice to reac-
tivate a new hair cycle after shaving the dorsal hair of the mice
(Sarin et al., 2005).Control andmutantmice receiveddoxycycline
pellets 2 days prior to shaving, and hair regrowth was monitored
daily for 4 weeks. Control mice regrew hair in the shaved area
within 28 days, whereas mutant mice failed to regenerate the
fur when treated with doxycycline (Figure 5D), even after a follow
up of more than 65 days (not shown). Thus, taken together, these
data suggest that Wnt1 may induce exiting of HF stem cells from
their quiescent state, whichmight contribute to the initial prolifer-
ative burst of epithelial cells in the HF, followed by the exhaustion
of the HF stem cell population.
A Role for mTOR in Wnt-Induced Cell Senescence
We next explored whether the remarkable effects induced by
Wnt on the HF were dependent on cell senescence cues gener-
ated by the stroma and the surrounding tissues. For that, we
cultured in vitro primary keratinocytes from control and K5rtTA/
tet-Wnt1 mice and controls. The expression of Wnt1 in vitro
could be achieved within the first 24 hr of doxycycline treatment,
as assessed by luciferase activity (Figure S5A). Concomitantly,
primary keratinocytes cells from K5rtTA/tet-Wnt1 mice showed
early evidence of senescence as judged by SAb-Gal staining
(Figure 6A). We also observed that Wnt1 expression caused
increased levels of pS6 (Figure 6B), similar to that of control cells
stimulated with EGF, suggesting that Wnt1 can regulate mTOR
activity in epithelial cells in vitro and in vivo. This observation
prompted us to explore whether mTOR contributes to the senes-
cence phenotype triggered by Wnt1 activation. For this, we took
advantage of the ability of rapamycin to inhibit the mTOR
pathway (Abraham, 2002). As shown in Figure 6C, exposure of
primary keratinocytes fromK5rtTA/tet-Wnt1mice to doxycycline
led to the appearance of cells exhibiting nuclear g-H2AX foci.
Surprisingly, however, rapamycin caused a reduction of the
number of cells displaying g-H2AX foci (Figure 6C). We next
took advantage of the observation that hair follicle epithelial
stem cells express CD34 in their cell surface (Blanpain et al.,
2004) to isolate CD34+ and CD34 keratinocytes and explore
the consequences of stimulating these cell populations with
Wnt (Figure 6D). When Wnt was exogenously added to their
culture medium, it caused the appearance of nuclear g-H2AX
foci in both CD34 and CD34+ cells, concomitant with the reduc-
tion in the number of cells expressing CD34 in CD34+-sorted cell
populations (Figure 6D). Although rapamycin did not affect the
basal expression of CD34 and g-H2AX (not shown), this mTOR
inhibitor prevented the accumulation of nuclear g-H2AX foci
and the decreased CD34 expression caused by exposing sorted
CD34+ keratinocytes to Wnt (Figure 6D, right panels).
On the basis of these results, we asked whether rapamycin
administration would affect any of the biological responses
provoked by Wnt1 expression in the skin of the K5rtTA/tet-284 Cell Stem Cell 5, 279–289, September 4, 2009 ª2009 Elsevier InWnt1 mice in vivo. We observed that the inhibition of mTOR by
rapamycin prevented the gross changes caused by Wnt1 in
the fur of the transgenic mice (Figure 7A, left). Rapamycin admin-
istration also abolished pS6 accumulation in the upper layers of
the interfollicular skin and in the IRS region of K5rtTA/tet-Wnt1
mice treated with doxycycline and the hyperproliferative
response to Wnt1 in the hair follicles and skin of these mice
(Figure 7A, right). Although rapamycin caused a reduction in
cell proliferation in both K5rtTA and K5rtTA/tet-Wnt1 mice
(Figure S5B), it did not impair the expression of the transgene
(Figure S5C) and the expression of the b-catenin reporter when
stimulated byWnt1 in K5rtTA/tet-Wnt1/Bat-gal mice (Figure 7B).
Rapamycin treatment prevented the accumulation of hair
follicles displaying nuclear g-H2AX foci upon Wnt1 expression
in vivo (Figures 7C and 7D), thus paralleling the results obtained
in vitro. Remarkably, rapamycin rescued the loss of CD34+
cells in the bulge region of the hair follicles of Wnt1-expressing
mice (Figures 7C and 7D). Indeed, although K5rtTA/tet-Wnt1
mice treated with rapamycin still had fewer hair follicles, the
vast majority of them retained an intact bulge stem cell compart-
ment. This suggests that mTOR function is critical in mediating
CD34+ epithelial cell loss in response to Wnt1, although addi-
tional rapamycin-insensitive mechanisms that may play a more
limited role might also exist. In fact, rapamycin prevented the
long-termWnt1-induced hair loss: K5rtTA/tet-Wnt1 mice treated
with doxycycline and rapamycin retained their hair for more than
40 days, a time at which most of these mice had a substantial
hair loss if treated with vehicle control instead of rapamycin
(not shown). Thus, the mTOR pathway appears to mediate the
hyperproliferative response and subsequent aging-like pheno-
type provoked by Wnt-1 expression in the skin, including the
exhaustion of its stem cell compartment.
DISCUSSION
Cells from embryonic tissues are able to divide for a restricted
number of times and then undergo cell division arrest until their
death. This phenomenon, known as replicative senescence
(Hayflick and Moorhead, 1961), is an irreversible process that
can be also triggered by a variety of conditions that result in
cellular stress, such as DNA-damage, exposure to cytotoxic
drugs and oxidative stress, telomerase dysfunction, and aber-
rant oncogene-induced proliferative signals, the latter known
as oncogene-induced senescence (OIS) (reviewed in Serrano
and Blasco, 2001). In normal (nonmalignant) cells, OIS or prema-
ture activation of senescence can be observed independently of
telomeric shortening (Serrano and Blasco, 2001). When initiated
by the activation of oncogenic signals, this irreversible process
leads to cell-cycle arrest, although cells remain alive and func-
tional. Here, we observed that expression of Wnt1 induces the
hyperproliferation of HF cells and the rapid exhaustion of their
stem cells, as reflected by the ablation of CD34+ cells in the HF
stem cell niche, concomitant with the activation of cell senes-
cence pathways. Activation of OIS in our animal model was re-
flected by the accumulation of the senescence marker g-H2AX
and SAb-gal and the absence of hair regrowth after shaving,
with the latter being a functional assay for hair follicle stem
activity in vivo (Sarin et al., 2005). We can speculate that the
demise of the stem cell reservoir upon persistent mitogenicc.
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Primary Epidermal Keratinocytes Causes
Cell Senescence through mTOR
(A) Primary cultures of keratinocytes derived from
K5rtTA and K5rtTA/tet-Wnt1 mice were treated
with doxycycline for 5 days. Detection of senes-
cence was observed in K5rtTA/tet-Wnt1 cells by
SA-bgal staining (indicated by arrows).
(B) Monolayers of keratinocytes from K5rtTA, tet-
Wnt1, and K5rtTA/tet-Wnt1 mice were starved
overnight and treated with doxycycline (24 hr).
Cells were lysed and analyzed by immunoblotting
for phosphorylated S6 (p-S6), total S6 (S6), and
tubulin content as a loading control. Total-cell
lysates from each mouse genotype without doxy-
cycline treatment were used as controls. Cells
from K5rtTA mice starved overnight and pre-
treated for 30 min with EGF (30 ng/ml) served as
additional controls.
(C) Primary culture of keratinocytes from trans-
genic mice were plated onto coverslips and
treated with doxycycline (1 mg/ml) with or without
rapamycin (50 nM) for 24 hr, as indicated. DAPI
nuclear staining and IF for g-H2AX, were per-
formed as indicated, and images were merged in
the right panel. Quantification of g-H2AX staining
in K5rtTA- and K5rtTA/tet-Wnt1-derived cells
treated with doxycycline plus vehicle or rapamycin
is shown. Data are represented as the percentage
of g-H2AX + cells, expressed as the average ±
SEM of ten fields at 203 magnification from
representative cells of the indicated genotype
and treatment (**p < 0.001, ns, p > 0 .05).
(D) Keratinocytes from 7-week-old mice were
sorted into two distinct cellular populations
(CD34+ and CD34). Sorted cells were plated in
collagen IV-coated dishes and treated as indi-
cated. Cells sorted for CD34 show membrane
CD34 staining in vehicle-treated cells, which was
lost concomitant with the nuclear accumulation
of g-H2AX foci when treated with Wnt3 for
6 days. CD34 cells also accumulated nuclear
g-H2AX foci in response to Wnt3. Rapamycin in-
hibited g-H2AX accumulation in both CD34+ and
CD34 cells and prevented the decreased expres-
sion of CD34 in CD34+-sorted keratinocytes
caused by Wnt3. Quantitative analysis of CD34
and g-H2AX staining of treated CD34+-sorted keratinocytes is shown in the right. Data are represented as the percentage of positive cells expressed as the
average ± SEM in triplicate cultures for each indicated treatment (***p < 0.001; **p < 0.01; ns, p > 0 .05).stimulation may act as a preventive strategy to avoid the incor-
poration of genetic alterations into self-renewing multipotent
cells, and thus its devastating consequences, including tumor
formation.
Wnt signaling is vital for axial patterning and progenitor cell
fate, as part of a regulatory signaling system conserved from flies
to humans (Nusse, 2008). Indeed, Wnts function in a wide range
of developmental processes (Chang et al., 2004; Olivera-Marti-
nez et al., 2001) aswell as in the control of proliferation and differ-
entiation (Moon et al., 2004; Nusse, 2008; Reya and Clevers,
2005). Aberrant activation of Wnt1 is associated with tumor
development in many organs including the mammary gland (re-
viewed in Lindvall et al., 2007). In our animal model, we were
surprised to find that epidermal activation of the Wnt1-initiated
pathway did not lead to tumor formation as expected on theCebasis of prior studies that used a stable, active form of b-catenin
(Gat et al., 1998). Instead, Wnt1 triggered HF to grow and main-
tain a persistent proliferative state rather than entering consecu-
tive cyclic programs of proliferation, regression, and resting
states. Most importantly, we did not find any signs of dysplasia,
metaplasia, or neoplasia, even after prolonged (>1 year) obser-
vation. A plausible explanation for the difference between the
epidermal phenotypes of the Wnt1 and b-catenin animal models
is that the emerging complexity of the Wnt-induced pathways
(Moon et al., 2004; Reya and Clevers, 2005) can only be partially
mimicked by the expression of truncated forms of b-catenin. In
this scenario, whereas active forms of b-catenin can promote
cancer progression, Wnt stimulates b-catenin but it may also
initiate the concomitant activation of cell senescence programs
thereby protecting from tumoral growth.ll Stem Cell 5, 279–289, September 4, 2009 ª2009 Elsevier Inc. 285
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mTOR and Stem Cell SenesceneFigure 7. Blockade of mTOR with Rapamy-
cin Protects from Hair Follicle Alterations,
Cell Senescence, and the Depletion of
CD34+ Epithelial StemCells Caused byWnt1
(A) Twenty-one-day-old mice fed with doxycycline
pellets received daily doses of rapamycin from
3 days of age, whereas control littermates re-
ceived only the vehicle. Rapamycin treatment pre-
vented the development of changes in the fur,
a phenotype that can be readily observed in of
K5rtTA/tet-Wnt1 mice treated with doxycycline
and vehicle control. Frozen sections were stained
for p-S6 immunoreactivity. Rapamycin treatment
prevented the activation of p-S6 in the IRS com-
partment and the histological changes caused by
doxycycline in K5rtTA/tet-Wnt1 mice, as observed
in H&E histological sections. Note the failure of the
lower half of the HF to regress in K5rtTA/tet-Wnt1
mice fed with doxycycline and the re-establish-
ment of a normal hair cycle (telogen) in these
mice upon rapamycin treatment.
(B) Rapamycin did not prevent the expression
from the b-catenin reporter system, as judged by
the detection of b-Gal in 14-day-old K5rtTA/tet-
Wnt1/BAT-Gal mice treated with doxycycline
and rapamycin.
(C) K5rtTA/tet-Wnt1 mice were fed with doxycy-
cline by 3 days of age, received daily IP injections
of rapamycin or vehicle, and were sacrificed at 21
days of age. Frozen sections of K5rtTA control
mice show the presence of CD34+ epithelial
stem cells in the bulge region of the HF and
absence of nuclear g-H2AX foci. Instead, K5rtTA/
tet-Wnt1 mice fed with doxycycline present a
high number of cells displaying g-H2AX staining
and lack of CD34+, but both were prevented by
the rapamycin treatment.
(D) Quantification of CD34+ and g-H2AX staining in
K5rtTA/tet-Wnt1 mice fed with doxycycline
treated with vehicle control or rapamycin. Data
are represented as the percentage of HF display-
ing CD34+ cells, expressed as the average ±
SEM of ten fields at 203magnification from repre-
sentative animals of the indicated genotype and
treatment (***p < 0.001, *p < 0.05), and as the
percentage of nuclei exhibiting g-H2AX positive
foci, expressed as the average ± SEM after count-
ing 300 HF cells at 203 magnification from repre-
sentative animals of the indicated genotype and
treatment (**p < 0.01; ns, p > 0 .05).Each new hair cycle is initiated when epidermal stem cells
located in the bulge region migrate to the bulb area of the HF
where they proliferate and give raise to all cell lineages present
in the HF (Alonso and Fuchs, 2003; Morris et al., 2004). In this re-
gard, the appropriate balance between the proliferative and
quiescent states is critical to maintaining a functional stem cell
compartment (Cheng et al., 2000; Kobielak et al., 2007). Thus,
the proper regulation of cycles of growth and rest may enhance
the lifespan of HF stem cells and lengthen the overall time that
hair is present as the animals age. Indeed, the fact that maintain-
ing a persistent HF growth phase results in the disappearance of
its stem cell compartment suggests that this cyclic growth and
rest may be required to preserve the self-renewal capacity of
epidermal stem cells, which under normal circumstances prolif-286 Cell Stem Cell 5, 279–289, September 4, 2009 ª2009 Elsevier Inerate only rarely (Alonso and Fuchs, 2003; Kobielak et al., 2007;
Morris et al., 2004). We interpret our results to show that
constant proliferation of the HF structures results in the exhaus-
tion of their stem cell pool, ultimately leading to premature hair
loss.
The impact of Wnt expression on the stem cells is likely to be
highly tissue specific. For example, whenWnt1 is overexpressed
in the mammary, a rapid expansion of its stem cell compartment
is observed (Cho et al., 2008; Li et al., 2000), thereby possibly
contributing to tumor formation upon acquisition of genetic
alterations in tumor suppressor pathways, including p53 (Debies
et al., 2008). In the case of the HF, however, their stem cells may
be particularly prone to senescence upon aberrant activation of
pro-proliferative pathways. This may represent an overridingc.
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mTOR and Stem Cell Senesceneprotective mechanism considering that epithelial cells in the hair
follicles and skin have to withstand multiple environmental DNA-
damaging agents (Cang et al., 2007). We can hypothesize that
under oncogenic stress or upon persistent growth promotion,
the stem cell compartment of HF might be transiently expanded,
but eventually becomes exhausted, therefore halting the carci-
nogenic process by limiting the life-span and self-renewing
capacity of their stem cells. Indeed, this scenario may in turn
explain the tissue-specific nature of the response to Wnt1
expression, which can cause either cell senescence or tumors
formation, depending on the presence or not of specific protec-
tive antitumoral mechanism in each particular stem cell popula-
tion.
On the other hand, although ectopic activation of the mTOR
pathway has been implicated in tumor progression (Sabatini,
2006; Shaw and Cantley, 2006), mTOR also controls the life
span in C. elegans, yeast, worms, and Drosophila (reviewed in
Schieke and Finkel, 2006), with decreased function of mTOR
leading to an increase in the life span (reviewed in Powers
et al., 2006). Here, we provide evidence that mTOR represents
a key downstream component of the pathway by which Wnt1
activation can lead to cell growth and tissue aging. Wnt activates
mTOR by a recently elucidatedmechanism that involves the inhi-
bition of GSK3 (Inoki et al., 2006). In this case, GSK3 enhances
the activity of the tumor suppressor protein TSC2, a GTPase
activating protein that diminishes the GTP-bound levels of
RheB1, a small GTPase that activates mTOR. Thus, by inhibiting
GSK3, Wnt reduces the inhibitory effect of TSC2 on mTOR, re-
sulting in enhanced mTOR function (Inoki et al., 2006). Indeed,
activation of mTOR, as judged by pS6 accumulation, occurred
in the same cell compartment in which we observed the
increased expression from a b-catenin reporter system and the
enhanced expression of a Wnt-regulated protein, WISP-1, sup-
porting that the stimulation of mTOR is a direct consequence
of Wnt1 expression. This activation of mTOR by Wnt1 contrib-
utes to the aberrant growth of mammary gland cells (Inoki
et al., 2006). In the skin, however, the mTOR-dependent persis-
tent proliferation of epithelial cells within the HF in response to
Wnt1, or the direct activation of mTOR in HF stem cells, may
result in the exhaustion of the HF stem cell compartment. In
this scenario, excessive proliferation and activation of mTOR in
stem cells may increase their turnover, prematurely exhausting
the ability of these stem cells to repopulate the hair follicle.
Consistent with this, pharmacological inhibition ofmTORwith ra-
pamycin was sufficient to prevent stem cell ablation upon Wnt1
expression, as reflected the maintenance of the population of
CD34+ bulge stem cells. mTOR inhibition also impaired the
acquisition of a premature senescence phenotype caused by
Wnt1 expression in mice and by the exposure of CD34+ cells
to Wnt, thus raising the possibility that mTOR may contribute
to OIS when triggered by the aberrant activity of other onco-
genes; such a result will warrant further investigation.
The emerging picture from our study and recent published
reports is that Wnt1 may promote the proliferation and regener-
ative capacity of tissue-specific stem cells (Katoh and Katoh,
2007) and that mTOR may play a key role as part of the
growth-promoting pathway by which Wnt acts (Inoki et al.,
2006). Long-term activation of Wnt, however, may cause cell
senescence and the exhaustion or demise of the stem cellCecompartment by the persistent activation of mTOR. Although
the exhaustion of the stem cells may act as a protective mecha-
nism against oncogenic perturbation of this particular self-
renewing cell population, the persistent activation of mTOR
may also contribute to accelerating aging, hence providing a
potential molecular target for pharmacological intervention in
multiple diseases that are characterized by the pathological
depletion of stem cells, loss of tissue regenerative capacity,
and tissue aging.
EXPERIMENTAL PROCEDURES
Experimental Mice
All animal studies were carried out according to NIH-approved protocols, in
compliance with the Guide for the Care and Use of Laboratory Animals.
FVB/N mice carrying the cytokeratin 5 promoter in the reverse tetracycline
transactivator (rTA) (k5-tet-on) and Wnt1-transgenic mouse expressing Wnt1
and IRES-firefly luciferase downstream of the seven tet-responsive elements
have been previously described (Gunther et al., 2003; Vitale-Cross et al.,
2004). Doxycycline grain-based pellets (Bioserv) were administered in a
concentration of 6 g/kg. To determine the canonical Wnt activation status
during the HF cycle, we used the b-catenin-activated transgene driving
expression of nuclear b-galactosidase reporter (BAT-Gal) transgenic mice
(Maretto et al., 2003). All transgenic lines were maintained on an FVB/N back-
ground. See Supplemental Data for additional procedures.
BrDU, Cell Proliferation Assay, and Primary Culture
of Murine Keratinocyte
Cell proliferation study was conducted after injection of BrDU (100mg/g body
weight) 2 hr before sacrificing the animals. Primary culture of keratinocytes
and [3H]-thymidine incorporation was performed as previously described
(Castilho et al., 2007), with the administration of doxycycline (1 mg/ml) concom-
itant or not with the administration of rapamycin (50 nM) for 48 hr. Sorted cells
were assessed for viability with trypan blue (Sigma) staining and cultured on
collagen-coated dishes with 15% serum and 0.3 mM of calcium. For immuno-
fluorescence staining, cells were plated in collagen-coated glass slides.
FACS Analysis and Cell Sorting
Seven-week-old K5rtTA/Wnt1mice and control littermates were used for each
experiment, as previously described (Blanpain et al., 2004). In brief, the
subcutis underlying the dorsal skin was removed with a scalpel, and the skin
was trypsinized for 2 hr at 37C and filtered through a 70 mm mesh filter (BD
Bioscience) so that single-cell suspension could be achieved. Cells were
incubated with 2% FCS in PBS on ice for 30 min and then incubated with
the primary antibody (CD34, 1:100; CD49f, 1:50) coupled with FITC and PE/
Cye5 fluorochrome, respectively, for 30 min. FACS analysis was performed
in a FACSCalibur flow cytometer (BD Bioscience). Cell sorting was performed
in a DAKO-Cytomation MoFlo High Speed Sorter.
Reporter Assays
Reporter assays were performed as described previously (Squarize et al.,
2006). Please find a brief description of the technique in the Supplemental
Data.
IHC, IF, Antibodies, Reagents, and Immunoblotting
Please find detailed information in the Supplemental Data.
Rapamycin Administration
Rapamycin (LC Laboratories) was administered through intraperitoneal
injections at a dose of 4 mg/kg per day for the indicated time.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and five
figures and can be found with this article online at http://www.cell.com/
cell-stem-cell/supplemental/S1934-5909(09)00301-4.ll Stem Cell 5, 279–289, September 4, 2009 ª2009 Elsevier Inc. 287
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